Societal CDMO IncNASDAQ:SCTL
- LAST PRICE1.3500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.3300/ 1
- Ask / Lots1.8400/ 2
- Open / Previous Close1.3600 / 1.3500
- Day Range
- 52 Week Range
- Volume42,830
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SCTL |
|---|---|---|
| 09:32 ET | 177 | 1.36 |
| 09:33 ET | 1000 | 1.36 |
| 09:35 ET | 100 | 1.375 |
| 09:48 ET | 100 | 1.34 |
| 09:53 ET | 100 | 1.3446 |
| 09:55 ET | 100 | 1.3401 |
| 09:57 ET | 100 | 1.3401 |
| 10:00 ET | 300 | 1.3401 |
| 10:02 ET | 200 | 1.3446 |
| 10:04 ET | 400 | 1.34 |
| 10:06 ET | 100 | 1.3401 |
| 10:08 ET | 100 | 1.3401 |
| 10:11 ET | 100 | 1.34 |
| 10:54 ET | 100 | 1.37 |
| 11:00 ET | 100 | 1.34 |
| 11:32 ET | 100 | 1.37 |
| 12:44 ET | 100 | 1.3699 |
| 01:11 ET | 400 | 1.355 |
| 01:22 ET | 200 | 1.35 |
| 01:26 ET | 625 | 1.35 |
| 01:36 ET | 100 | 1.34 |
| 01:42 ET | 500 | 1.35 |
| 01:58 ET | 100 | 1.35 |
| 02:09 ET | 3000 | 1.36 |
| 02:21 ET | 100 | 1.35 |
| 02:25 ET | 27234 | 1.3575 |
| 02:41 ET | 300 | 1.37 |
| 02:52 ET | 100 | 1.35 |
| 02:56 ET | 100 | 1.34 |
| 03:01 ET | 200 | 1.36 |
| 03:10 ET | 200 | 1.36 |
| 03:17 ET | 100 | 1.34 |
| 03:26 ET | 100 | 1.34 |
| 03:32 ET | 600 | 1.36 |
| 03:33 ET | 100 | 1.34 |
| 03:37 ET | 100 | 1.34 |
| 03:44 ET | 200 | 1.36 |
| 03:48 ET | 489 | 1.35 |
| 03:50 ET | 400 | 1.34 |
| 03:51 ET | 100 | 1.35 |
| 03:53 ET | 200 | 1.35 |
| 03:57 ET | 200 | 1.34 |
| 04:00 ET | 100 | 1.35 |
Jan 6, 2023
Societal CDMO Reports Inducement Grants for New Staff, from 7:00AM ET on Friday Jan 06, 2023 by GlobeNewswire
7:00AM ET on Friday Jan 06, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Societal CDMO Inc | 114.1M | -5.6x | --- |
OptiNose Inc | 193.8M | -1.8x | --- |
Interpharm Holdings Inc | 70.0 | 0.0x | --- |
Journey Medical Corp | 25.6M | -0.8x | --- |
Qilian International Holding Group Ltd | 48.3M | 54.2x | --- |
Praxsyn Corp | 790.0 | 0.0x | --- |
Company Information
Societal CDMO, Inc. is a bi-coastal contract development and manufacturing organization (CDMO). The Company is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus on the area of small molecules. It is involved in CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. Its key products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, Donnatal liquids and tablets and Scot-Tussin cough and cold liquids. Its manufacturing and development capabilities include formulation, product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms, extended-release and controlled substance manufacturing.
Contact Information
- Headquarters
- 1 E. UWCHLAN AVE, SUITE 112EXTON, PA, United States 19341
- Phone
- 770-534-8239
- Fax
- 484-395-2471
Executives
- Independent Chairman of the Board
- Wayne Weisman
- President, Chief Executive Officer, Director
- J. David Enloe
- Chief Financial Officer
- Ryan Lake
- Independent Director
- William Ashton
- Independent Director
- Michael Berelowitz
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $114.1M |
|---|---|
Revenue (TTM) | $88.2M |
Shares Outstanding | 84.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-0.24 |
Book Value | $0.90 |
P/E Ratio | -5.6x |
Price/Sales (TTM) | 1.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | 0.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
